Federal Contractor Profile
Lovelace Biomedical Research Institute
$137M obligated·169 awards·6 agencies·14 NAICS
Federal Contracts
Showing award actions 101–150 of 209 funded award actions, most recent first.
- Contracts with positive obligations
- 169
- Funded award actions shown
- 209
- Obligations shown
- $137M
- Awarding agencies
- 6
This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.
Award data as of November 5, 2026. Source: USAspending federal award records.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Oct 30, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95020F00002 | 541715 | CHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN PERIOD OF PERFORMANCE SEPTEMBER 18, 2020 - SEPTEMBER 17, 2022 | $32K |
| Oct 13, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93021F00001 | 541715 | THE PURPOSE OF THIS TASK ORDER IS TO FUND THE GUARANTEED MINIMUM AMOUNT OF THE CONTRACT. | $3K |
| Sep 24, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95020F00003 | 541715 | NATURAL HISTORY STUDIES IN NEUROMUSCULAR JUNCTION (NMJ) DISEASE MOUSE MODELS. PERIOD OF PERFORMANCE SEPTEMBER 28, 2020 - DECEMBER 31, 2021 | $1.5M |
| Sep 24, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95020F00005 | 541715 | EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN PROPIONIC ACIDEMIA (PA) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT. PERIOD OF PERFORMANCE SEPTEMBER 25, 2020 - SEPTEMBER 24, 2022 | $1.7M |
| Sep 23, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95020F00001 | 541712 | NON-CLINICAL SAFETY ASSESSMENT OF GENE THERAPY (PCCA, MMAB, DOK7 AND COLQ) TO SUPPORT PLATFORM GENE THERAPY FOR CONGENITAL MYASTHENIC DISEASES (DOK7, COLQ) AND ACIDEMIA (PCCA, MMAB) | $2.3M |
| Sep 22, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95020F00004 | 541715 | CHARACTERIZATION OF A DOWNSTREAM GENE THERAPEUTIC FOR THE REPARATIVE TREATMENT OF SEVERE FRACTURES PERIOD OF PERFORMANCE SEPTEMBER 24, 2020 - NOVEMBER 23, 2021 | $700K |
| Sep 17, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NHLBI | 75N92020F00002 | 541714 | GTRP: PHARMACOLOGY/TOXICOLOGY CORE LABORATORY PROJECT FOR RSA NO. 2034 | $1.1M |
| Sep 15, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95020F00002 | 541715 | CHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN PERIOD OF PERFORMANCE SEPTEMBER 18, 2020 - SEPTEMBER 17, 2022 | $345K |
| Sep 14, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95020F00001 | 541715 | TASK ORDER ENTITLED, "PHARMACODYNAMICS OF THE MAS-RELATED GENE X2 (MRGX2) ANTAGONIST SYR268215 IN THE HUMANIZED MRGX2 KNOCK-IN (KI) MOUSE." | $177K |
| Sep 13, 2020 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | HHSF22301002T | 541720 | IGF::CL::IGF | $141K |
| Aug 26, 2020 | Department of DefenseW6QK ACC-APG NATICK | 0011 | 541712 | IGF::OT::IGF OMNIBUS III / O3-127AF PAIN MANAGEMENT PROGRAM MANAGEMENT SUPPORT | $263K |
| Aug 21, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95018F00002 | 541712 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE: TO PERFORM NON-CLINICAL SAFETY ASSESSMENT OF TTHX1114 TO SUPPORT FUCHS ENDOTHELIAL CORNEAL DYSTROPHY IND APPLICATION. | $614K |
| Aug 18, 2020 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH17C0235 | 511210 | IGF::OT::IGF ANIMAL MANAGEMENT SYSTEM SOFTWARE LICENSE/SUPPORT | $196K |
| Jul 21, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95019F00089 | 541715 | EVALUATION OF DRUG EFFICACY IN A GUINEA PIG MODEL OF NEONATAL OPIOID WITHDRAWAL SYNDROME | $76K |
| Jun 30, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93020F00001 | 541711 | PRE-CLINICAL MODELS OF INFECTIOUS DISEASES TASK ORDER B07 | $669K |
| Jun 24, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93019F00131 | 541712 | TRANSFER AND VALIDATION OF BIOANALYTICAL METHOD FOR DETECTION OF CABOTEGRAVIR IN RAT PLASMA | $76K |
| Jun 5, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NHLBI | 75N92020F00001 | 541714 | GENE THERAPY RESEARCH PROGRAM (GTRP) - PHARMACOLOGY/TOXICOLOGY CORE LABORATORY: TASK AREA D - RSA NO. 2041 | $317K |
| May 5, 2020 | Department of DefenseFA9451 AFRL RDK | FA945120P0019 | 541380 | COVID-19 THE PURPOSE OF VIDER IS TO UNDERSTAND THE EFFECTIVENESS OF RF DIRECTED ENERGY RADIATION IN REDUCING THE VIABILITY OF VIRAL AEROSOLS WITH THE GOAL OF RAPIDLY DEVELOPING AND DEPLOYING REMEDIATION METHODS FOR SPACES CONTAMINATED WITH SARS-COV-2 | $192K |
| May 1, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120F33002 | 541711 | PROJECT RTOR BIO-AMT-1021: DEVELOPMENT OF ANIMAL MODELS FOR EVALUATION OF MEDICAL COUNTERMEASURES FOR SARS-COV-2 | $2.2M |
| Mar 30, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120F33002 | 541711 | PROJECT RTOR BIO-AMT-1021: DEVELOPMENT OF ANIMAL MODELS FOR EVALUATION OF MEDICAL COUNTERMEASURES FOR SARS-COV-2 | $3.0M |
| Mar 28, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 75A50120F33002 | 541711 | PROJECT RTOR BIO-AMT-1021: DEVELOPMENT OF ANIMAL MODELS FOR EVALUATION OF MEDICAL COUNTERMEASURES FOR SARS-COV-2 | $939K |
| Mar 27, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95018F00002 | 541712 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE: TO PERFORM NON-CLINICAL SAFETY ASSESSMENT OF TTHX1114 TO SUPPORT FUCHS ENDOTHELIAL CORNEAL DYSTROPHY IND APPLICATION. | $269K |
| Mar 20, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO10033002T | 541711 | IGF::OT::IGF FOR OTHER FUNCTIONS | $6K |
| Mar 11, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95019F00088 | 541715 | DISEASE MODEL CHARACTERIZATION AND DEVELOPMENT OF ASSAYS TO EVALUATE AND MEASURE PAIN IN A PORCINE MODEL FOR SICKLE CELL DISEASE (SCD) | $57K |
| Jan 16, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95019F00089 | 541715 | EVALUATION OF DRUG EFFICACY IN A GUINEA PIG MODEL OF NEONATAL OPIOID WITHDRAWAL SYNDROME | $16K |
| Dec 17, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NHLBI | 75N92019F00074 | 541714 | THE NHLBI REQUIRES THE GENE THERAPY RESOURCE PROGRAM (GTRP) SUPPORT TRANSLATIONAL GENE THERAPY RESEARCH BY PROVIDING RESOURCES AND SERVICES FROM THREE CORE LABORATORIES: 1.) PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY, 2.) PRECLINICAL VECTOR CORE LABORATORY, 3.) CLINICAL COORDINATING CENTER (CCC), WHICH IS NOT REQUIRED TO HAVE ANY LABORATORY CAPABILITIES. | $492K |
| Sep 26, 2019 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 75F40119C10161 | 541380 | STUDY OF E-CIGARETTE AEROSOL TOXICITY IN IN VIVO NONCLINICAL MODELS. | $36M |
| Sep 24, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95019F00089 | 541715 | EVALUATION OF DRUG EFFICACY IN A GUINEA PIG MODEL OF NEONATAL OPIOID WITHDRAWAL SYNDROME | $239K |
| Sep 24, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95019F00090 | 541715 | EVALUATION OF DRUG EFFICACY IN A RAT MODEL OF NEUROPATHIC PAIN | $356K |
| Sep 23, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95019F00088 | 541715 | CONTRACT KICKOFF CONFERENCE CALL FOR CRO SUPPORT FOR NCATS MEDICINAL CHEMISTRY FOR LEAD OPTIMIZATION. | $5K |
| Sep 9, 2019 | Department of DefenseW6QK ACC-APG NATICK | 0011 | 541712 | IGF::OT::IGF OMNIBUS III / O3-127AF PAIN MANAGEMENT PROGRAM MANAGEMENT SUPPORT | $256K |
| Aug 26, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95019F00088 | 541715 | DISEASE MODEL CHARACTERIZATION AND DEVELOPMENT OF ASSAYS TO EVALUATE AND MEASURE PAIN IN A PORCINE MODEL FOR SICKLE CELL DISEASE (SCD) | $2.0M |
| Aug 14, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95019F00088 | 541715 | DISEASE MODEL CHARACTERIZATION AND DEVELOPMENT OF ASSAYS TO EVALUATE AND MEASURE PAIN IN A PORCINE MODEL FOR SICKLE CELL DISEASE (SCD) | $124K |
| Aug 2, 2019 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH17C0235 | 511210 | IGF::OT::IGF ANIMAL MANAGEMENT SYSTEM SOFTWARE LICENSE/SUPPORT | $191K |
| Jul 18, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID | 75N93019F00131 | 541712 | TRANSFER AND VALIDATION OF BIOANALYTICAL METHOD FOR DETECTION OF CABOTEGRAVIR IN RAT PLASMA | $274K |
| Jun 28, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95019F00088 | 541715 | DISEASE MODEL CHARACTERIZATION AND DEVELOPMENT OF ASSAYS TO EVALUATE AND MEASURE PAIN IN A PORCINE MODEL FOR SICKLE CELL DISEASE (SCD) | $834K |
| May 7, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95018F00002 | 541712 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE: TO PERFORM NON-CLINICAL SAFETY ASSESSMENT OF TTHX1114 TO SUPPORT FUCHS ENDOTHELIAL CORNEAL DYSTROPHY IND APPLICATION. | $629K |
| Apr 8, 2019 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO10033001T | 541711 | IGF::OT::IGF | $409K |
| Mar 20, 2019 | Department of Health and Human ServicesPROGRAM SUPPORT CENTER ACQ MGMT SVC | HHSP233201300316G | 541380 | IGF::OT::IGF SCIENTIFIC SUPPORT SERVICES FOR THE NAVY ENTOMOLOGY CENTER OF EXCELLENCE | $147K |
| Jan 3, 2019 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | HHSF22301004T | 541712 | IGF::OT::IGF EVALUATION OF E-CIGARETTE AEROSOL IN IN VIVO NONCLINICAL MODELS | $173K |
| Dec 19, 2018 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NHLBI | 75N92019F00074 | 541714 | THE NHLBI REQUIRES THE GENE THERAPY RESOURCE PROGRAM (GTRP) SUPPORT TRANSLATIONAL GENE THERAPY RESEARCH BY PROVIDING RESOURCES AND SERVICES FROM THREE CORE LABORATORIES: 1.) PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY, 2.) PRECLINICAL VECTOR CORE LABORATORY, 3.) CLINICAL COORDINATING CENTER (CCC), WHICH IS NOT REQUIRED TO HAVE ANY LABORATORY CAPABILITIES. | $291K |
| Oct 3, 2018 | Department of DefenseNAVAL MEDICAL LOGISTICS COMMAND | 0002 | 541712 | CRA SUPPORT SERVICES | $34K |
| Sep 28, 2018 | Department of DefenseNAVAL MEDICAL LOGISTICS COMMAND | 0007 | 541712 | OMNIBUS III / 03-100 DISEASE SURVEILLANCE AND CLINICAL STUDY SUPPORT SERVICES FOR NHRC- PROJECT X. IGF::OT::IGF | $1.0M |
| Sep 26, 2018 | Department of DefenseNAVAL MEDICAL LOGISTICS COMMAND | 0007 | 541712 | OMNIBUS III / 03-100 DISEASE SURVEILLANCE AND CLINICAL STUDY SUPPORT SERVICES FOR NHRC- PROJECT X. IGF::OT::IGF | $106K |
| Sep 20, 2018 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95018F00002 | 541712 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE: TO PERFORM NON-CLINICAL SAFETY ASSESSMENT OF TTHX1114 TO SUPPORT FUCHS ENDOTHELIAL CORNEAL DYSTROPHY IND APPLICATION. | $565K |
| Sep 13, 2018 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95018F00002 | 541712 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE: TO PERFORM NON-CLINICAL SAFETY ASSESSMENT OF TTHX1114 TO SUPPORT FUCHS ENDOTHELIAL CORNEAL DYSTROPHY IND APPLICATION. | $883K |
| Sep 12, 2018 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 75F40118D10034 | 541715 | IGF:CL:IGF - ASSESSMENT OF TOBACCO PHARMACOLOGY AND HUMAN BEHAVIORS IN NONCLINICAL MODELS | $1K |
| Aug 30, 2018 | Department of DefenseNAVAL MEDICAL LOGISTICS COMMAND | 0007 | 541712 | OMNIBUS III / 03-100 DISEASE SURVEILLANCE AND CLINICAL STUDY SUPPORT SERVICES FOR NHRC- PROJECT X. IGF::OT::IGF | $226K |
| Aug 28, 2018 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO10033002T | 541711 | IGF::OT::IGF FOR OTHER FUNCTIONS | $3.4M |
| Aug 27, 2018 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH17C0235 | 511210 | IGF::OT::IGF ANIMAL MANAGEMENT SYSTEM SOFTWARE LICENSE/SUPPORT | $198K |
Get Alerted Before Lovelace Biomedical Research Institute's Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start for free